Net sales fell 41% year-over-year amid weak demand and high comparables, but product margin improved and the company executed its largest product launch to date. Market recovery is expected in 2025, with Q4 2024 anticipated to show renewed growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.